New York, NYCIK 17501834 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
2 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Aspire Biopharma Hldgs Inc | 202.9K | $26.8K | 88.6% | 0 | Held |
| 2 | Aspire Biopharma Hldgs Inc | 207.7K | $3.4K | 11.4% | 0 | Held |